Antifungal synergy of theaflavin and epicatechin combinations against Candida albicans

Journal of Microbiology and Biotechnology

Volumn 23, Issue 9, 2013, Pages 1322-1326

  Betts, Jonathan W ^a   Wareham, David W ^a   Haswell, Stephen J ^b   Kelly, Stephen M ^b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF HULL   (United Kingdom)

Author keywords

Antifungal; Candida albicans; Epicatechin; Synergy; Theaflavin

Indexed keywords

EPICATECHIN; POLYPHENOL; THEAFLAVIN;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; BIOASSAY; CANDIDA ALBICANS; CONTROLLED STUDY; DISK DIFFUSION; DRUG EFFECT; DRUG EFFICACY; DRUG POTENTIATION; DRUG SCREENING; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHYTOCHEMISTRY; TEA;

ANTIFUNGAL AGENTS; BIFLAVONOIDS; CAMELLIA SINENSIS; CANDIDA ALBICANS; CANDIDIASIS; CATECHIN; DRUG SYNERGISM; HUMANS; MICROBIAL SENSITIVITY TESTS; PLANT EXTRACTS;

EID: 84884691562     PISSN: 10177825     EISSN: 17388872     Source Type: Journal    
DOI: 10.4014/jmb.1303.03010     Document Type: Article

References (20)

1. Betts JW, Kelly SM, Haswell SJ. 2011. Antibacterial effects of theaflavin and synergy with epicatechin against clinical isolates of Acinetobacter baumannii and Stenotrophomonas maltophilia. Int. J. Antimicrob. Agents 35: 421-425.
2. Betts JW, Murphy C, Kelly SM, Haswell SJ. 2012. Minimum inhibitory and bactericidal concentrations of theaflavin and synergistic combinations with epicatechin and quercetin against clinical isolates of Stenotrophomonas maltophilia. J. Microbiol. Biotech. Food Sci. 1: 1250-1258.
3. Cho YS, Schiller NL, Oh KH. 2008. Antibacterial effects of green tea polyphenols on clinical isolates of methicillin-resistant Staphylococcus aureus. Curr. Microbiol. 57: 542-546.
4. Evensen NA, Braun PC. 2009. The effects of tea polyphenol on Candida albicans: inhibition of biofilm formation and proteasome inactiviation. Can. J. Microbiol. 55: 1033-1039.
5. Ferreira C, Silva S, Faria-Oliveira F, Pinho E, Henriques M, Lucas C. 2010. Candida albicans virulence and drug-resistance requires the O-actyltransferase Gup1p. BMC Microbiol. 10: 238.
6. Gordon NC, Wareham DW. 2010. Antimicrobial activity of the green tea polyphenol (-)-epigallocatechin-3-gallate against clinical isolates of Stenotrophomonas maltophilia. Int. J. Antimicrob. Agents 36: 129-131.
7. Hall MJ, Middleton RF, Westmacott D. 1983. The fractional inhibitory concentration (FIC) index as a measurement of synergy. J. Antimicrob. Chemother. 11: 427-433.
8. Hatano T, Tsugawa M, Kusuda M, Taniguchi S, Yoshida T, Shiota A, et al. 2008. Enhancement of antibacterial effects of epigallocatechin gallate, using ascorbic acid. Phytochemistry 69: 3111-3116.
9. Khan N, Mukhtar H. 2007. Tea polyphenols for health promotion. Life Sci. 81: 519-533.
10. Kim H, Kawazoe T, Han DW, Matsumara K, Tsutumi S, Hyon SH. 2008. Enhanced wound healing by an epigallocatechin-incorporated collagen sponge in diabetic mice. Wound Repair Regen. 16: 714-720.
11. Lambert JD, Yang CS. 2003. Cancer chemopreventive activity and bioavailability of tea and tea polyphenols. Mutat. Res. 523-524: 201-208.
12. Moodsdeen F, Williams JD, Secker A. 1988. Standardization of inoculum size for disc susceptibility testing: a preliminary report of a spectrophotometric method. J. Antimicrob. Chemother. 21: 439-443.
13. Neyestani TR, Khalaji N, Gharavi A. 2007. Black teas may have selective synergistic or antagonistic effects on certain antibiotics against Streptococcus pyogenes in vitro. J. Nutr. Environ. Med. 16: 258-266.
14. Okubo S, Toda M, Hara Y, Shimamura T. 1991. Antifungal and fungicidal activities of tea extract and catechin against Trichophyton. Nihon Saikingaku Zasshi 46: 509-514.
15. Park BJ, Park JC, Taguchi H, Fukushima K, Hyon SH, Takatori K. 2006. Antifungal susceptibility of epigallocatechin 3-O-gallate (EGCg) on clinical isolates of pathogenic yeasts. Biochem. Biophys. Res. Commun. 347: 401-405.
16. Pugliese A, Torre D, Baccino FM, Di Perri G, Cantamessa Gerbaudo L, Saini A, Vidotto V. 2000. Candida albicans and HIV-1 infection. Cell Biochem. Funct. 18: 235-241.
17. Sims CR, Ostrosky-Zeichner L, Rex JH. 2005. Invasive Candidiasis in immunocompromised hospitalized patients. Arch. Med. Res. 36: 660-671.
18. Sitheeque MA, Panagoda GJ, Yau J, Amarakoon AM, Udagama UR, Samaranayake LP. 2009. Antifungal activity of black tea polyphenols (catechins and theaflavins) against Candida species. Chemotherapy 55: 189-196.
19. White TC, Holleman S, Dy F, Mirels LF, Stevens DA. 2002. Resistance mechanisms in clinical isolates of Candida albicans. Antimicrob. Agents Chemother. 46: 1704-1713.
20. Yoda Y, Hu ZQ, Zhao WH, Shimamura T. 2004. Different susceptibilies of Staphylococcus and Gram-negative rods to epigallocatechin gallate. J. Infect. Chemother. 10: 55-58.